Home » Topics » BioWorld Science

BioWorld Science
RSS

SARS-CoV-2 vaccine shows promise in first peer-reviewed article on a potential COVID-19 vaccine

April 7, 2020

FDA clears IND application for EIDD-2801 for COVID-19

April 7, 2020

FDA accepts IND for phase I testing of INO-4800 for COVID-19

April 7, 2020

Pfizer discloses new CCR6 antagonists

April 7, 2020

Hanmi Science presents new EGFR mutant inhibitors

April 7, 2020

Bristol-Myers Squibb synthesizes new LPA1 receptor antagonists

April 7, 2020

Chinese researchers patent compounds for cancer

April 7, 2020

Ono Pharmaceutical divulges PTGDR2 antagonists

April 7, 2020

Novel alpha-ketoamide inhibitor with activity against main protease of SARS-CoV-2

April 7, 2020

IRF-1 as a novel therapeutic target in CKD

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...